Decision-Making Support for Prostate Cancer Screening

(PSA Trial)

Recruiting in Palo Alto (17 mi)

Overseen by Roshan Bastani, PhD

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Jonsson Comprehensive Cancer Center

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this intervention trial is aiming to increase inform decision- making in Latino men regarding prostate cancer screening. The investigators propose to find out how much Latino men know about the benefits and risks of prostate cancer screening and what factors influence how they decide whether or not to have screening. The investigators are also interested in learning how providing education information, both verbally and in print, about the risks and benefits of prostate cancer screening affects men's interest and knowledge. The intervention is an interactive multi-media presentation made up of a small group of 8-10 Latino men gathered to discuss about prostate cancer, screening methods, treatment, and the controversy within the medical community regarding PSA screening. A facilitator guides the 1-hour discussion and encourages participant interaction. The effect of this intervention was tested on 1000 Latino men within Los Angeles county. Participants were recruited from 38 community venues (churches, community center, etc.). All participants were interviewed before being randomized to receive written (control group) or oral (intervention) prostate cancer education material. All of the participants will be followed up at 6-months via a telephone interview. The investigators hypothesize that the intervention group will have an increase knowledge of prostate cancer, will have increase communication with family, friends, and medical provider, and will have an increase rate of PSA screening compared to the control group.

Research Team

Roshan Bastani, PhD

Principal Investigator

University of California, Los Angeles

Eligibility Criteria

This trial is for Latino men aged 50-70 in Los Angeles who have never had prostate cancer or a PSA test in the last year, and do not currently have prostate issues like pain during urination. Men with previous prostate surgery, biopsy, or outside the age range are excluded.

Inclusion Criteria

I am a Latino man.

I do not have prostate inflammation.

I have never had prostate cancer.

Exclusion Criteria

Having had a prostate biopsy

I am either under 50 or over 70 years old.

Living outside of Los Angeles county

Treatment Details

Interventions

• Intervention Session (Behavioral Intervention)
• Printed Material (Behavioral Intervention)

Trial Overview The study tests if an interactive session discussing prostate cancer screening can improve decision-making among participants compared to just receiving printed material. The impact on knowledge and screening rates will be assessed through follow-ups.

Participant Groups

Group I: 2 Experimental Treatment 1 Intervention

Printed material regarding general prostate cancer information provided.

Group II: 1 Experimental Treatment 1 Intervention

Educational small group session regarding prostate cancer

Who Is Running the Clinical Trial?

Jonsson Comprehensive Cancer Center

Lead Sponsor

Trials

373

Recruited

35,200+

Dr. Aparna Bhaduri

Jonsson Comprehensive Cancer Center

Chief Medical Officer since 2024

MD

Dr. Michael A. Teitell

Jonsson Comprehensive Cancer Center

Chief Executive Officer since 2024

MD, PhD

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+

Dr. Douglas R. Lowy

National Cancer Institute (NCI)

Chief Executive Officer since 2023

MD from New York University School of Medicine

Dr. Monica Bertagnolli

National Cancer Institute (NCI)

Chief Medical Officer since 2022

MD from Harvard Medical School